WuXi AppTec strengthens gene therapy offerings with OXGENE acquisition
WuXi AppTec has concluded the acquisition of UK-based contract research and development organisation OXGENE to boost its cell and gene…
Latest Deals
-
NAMergers & Acquisitions Undisclosed
-
TakedaLicensing Agreement $1.25BN
-
GraceMergers & Acquisitions $570M
-
MerckMergers & Acquisitions $1.85BN
-
NAMergers & Acquisitions Undisclosed
-
TakedaLicensing Agreement $1.25BN
-
GraceMergers & Acquisitions $570M
-
MerckMergers & Acquisitions $1.85BN
CRUK teams up with Teon to trial first-in-class cancer drug
Cancer Research UK (CRUK) has signed a clinical development collaboration with California-based Teon Therapeutics. Teon’s work focuses on developing a…
Latest News
View More
Cerecor’s antibody reduces respiratory failure in Covid-19 ARDS trial
Cerecor has reported that final efficacy data from Phase II trial of human anti-LIGHT (TNFSF14) monoclonal antibody, CERC-002, in hospitalised patients with Covid-19 linked pneumonia…
CRUK teams up with Teon to trial first-in-class cancer drug
Cancer Research UK (CRUK) has signed a clinical development collaboration with California-based Teon Therapeutics. Teon’s work focuses on developing a portfolio of immunotherapies for cancer…
Hackers reportedly target Indian Covid-19 vaccine makers Serum Institute, Bharat Biotech
A Chinese hacking group has reportedly targeted the IT systems of two Indian Covid-19 vaccine makers, the Serum Institute of…
Business optimism remains unchanged in February: Poll
Global Covid-19 vaccination drives have renewed hopes for recovery, but businesses remain cautious over outlook. Verdict has been conducting a…
WHO panel advises against use of hydroxychloroquine to prevent Covid-19
The World Health Organization’s (WHO) Guideline Development Group (GDG) expert panel has made a recommendation against the use of the…
Veru to progress Covid-19 drug into Phase III study
Veru is set to advance its drug VERU-111 into a Phase III registration clinical study on hospitalised high-risk Covid-19 patients…
Company A-Z
View More
Latest Content
View More
Q&A with SVB’s Nooman Haque: what does 2021 have in store for healthcare investment?
In a recently-published annual report of the healthcare investment landscape, Silicon Valley Bank (SVB) found that 2020 was a record…
Beyond the lung: treating the GI symptoms of Covid-19
If you want to book a free Covid-19 test in the UK, you must have at least one of three…
R-Pharm to Use Frewitt Milling Technology
R-Pharm, a Russian medical company, has announced they will be using fine micronisation technology from Swiss mill manufacturer Frewitt. The…
Unlocking the Power of a Connected Workforce
The way organizations have been connecting workers to the digital space is expensive, slow, and difficult for users. It also…
Covid-19 Vaccine Distribution Monitoring Made Easy
The global Covid-19 vaccines distribution task is a complicated operation and implementing an easy solution to monitor this process is…
Cell Harvest Using Only One Filter Per Batch
As the biologics industry is moving towards more diverse batch volumes and cell concentrations that are cultivated in single-use facilities,…